Literature DB >> 30101855

Outcomes in Patients with Critical Limb Ischemia due to Arteriosclerosis Obliterans Who Did Not Undergo Arterial Reconstruction.

Daisuke Akagi1, Katsuyuki Hoshina1, Atsushi Akai1, Kota Yamamoto1.   

Abstract

The prevalence of arteriosclerosis obliterans (ASO) and critical limb ischemia (CLI) is currently increasing, and arterial reconstruction is often attempted to salvage the limb. Some patients cannot undergo attempted revascularization because of contraindications, and they only receive conservative treatment. In this study, we investigate the comorbidities and survival rates of patients with CLI who receive conservative treatment. Thirty-five patients with CLI due to ASO, who had not undergone revascularization surgery (C group), were enrolled. As controls, 136 patients with CLI due to ASO who did undergo revascularization (R group), mainly via bypass surgery, were enrolled. Coronary artery disease, heart failure, and respiratory dysfunction were factors indicating conservative treatment. Limb salvage rates and survival rates were not significantly different between the two groups. Patients who had survived for less than two years after surgery had a higher prevalence of chronic heart failure, cardiovascular disease, and end-stage renal disease compared to patients who had survived for more than two years. The use of statins, dual antiplatelets, aspirin, or warfarin did not influence whether a patient survived for longer than two years. 77% of patients survived for more than two years after receiving only conservative therapies. Surgical revascularization did not improve the prognosis of patients with CLI as compared with the conservative therapy. Clinicians might start with conservative treatment while considering other treatment options for patients with CLI.

Entities:  

Keywords:  Comorbidities; Conservative treatment; Drug therapy; Limb salvage; Peripheral artery disease; Revascularization; Survival

Mesh:

Year:  2018        PMID: 30101855     DOI: 10.1536/ihj.17-592

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  5 in total

Review 1.  Therapeutic Alternatives in Diabetic Foot Patients without an Option for Revascularization: A Narrative Review.

Authors:  Gerhard Ruemenapf; Stephan Morbach; Martin Sigl
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

2.  Protective effect of rivaroxaban on arteriosclerosis obliterans in rats through modulation of the toll-like receptor 4/NF-κB signaling pathway.

Authors:  Xinjiang Lou; Zhi Yu; Xiaoxia Yang; Jie Chen
Journal:  Exp Ther Med       Date:  2019-07-03       Impact factor: 2.447

3.  Ameliorative effects of the traditional Chinese medicine formula Qing-Mai-Yin on arteriosclerosis obliterans in a rabbit model.

Authors:  Lei Zhang; Jia-Qin Yuan; Fu-Chen Song; Mei-Dong Zhu; Qi Li; Sheng-Hua Liu; Kai Zhao; Cheng Zhao
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

4.  TurboHawk plaque rotation system for treatment of arteriosclerosis occlusion in lower extremities: A pilot retrospective study.

Authors:  Zhao Yuan; Bo Yang; Jian Wang; Huan-Song An; Hai Xu
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

5.  Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors.

Authors:  Deshuang Xiao; Jun Song
Journal:  Comput Math Methods Med       Date:  2022-08-04       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.